The Leukemia & Lymphoma Society rings Nasdaq bell to mark 75 years of progress and announce its bold goal for the future
The organization will enable blood cancer patients to gain one million years of life by 2040
RYE BROOK, N.Y., Jan. 31, 2025 /PRNewswire/ -- Celebrating its 75th year of progress toward its mission to cure blood cancer and improve the quality of life of all patients and their families, The Leukemia & Lymphoma Society (LLS), founded on this day in New York in 1949, announced a bold goal for the future: to enable blood cancer patients to gain more than one million years of life by 2040.
This bold goal, supported by a new organizational strategy, builds on decades of LLS work that is already contributing to longer and better lives for patients with every type of blood cancer all over the world. Gaining one million years of life means more birthdays, graduations, weddings, holidays and memories shared with family and friends.
The moment was marked by the ceremonial ringing of the Nasdaq opening bell as a lead-up to World Cancer Day on Feb. 4. Thanks to a gift from The Orokawa Foundation, all donations to LLS on Feb. 4 will be matched dollar-for-dollar up to $75,000 to mark the culmination of LLS's 75-year milestone.
'Every day, blood cancer patients ring the bell marking milestones in their treatment. Thanks to scientific innovation, patient support and advocacy fueled by LLS over 75 years, today we ring the bell for all blood cancer patients – as we announce our bold goal for the future,' said E. Anders Kolb, M.D., president and CEO of LLS.
'Our bold goal represents the additional years of life we can gain through continued innovation and collaboration. We're endeavoring beyond today's achievements to accelerate the pace of discovery and access to care to add one million more years of life on top of our current trajectory,' he said.
As the world's leading organization dedicated to ending blood cancer, LLS has already made tremendous strides over the past several decades. LLS has invested more than $1.8 billion in blood cancer research, resulting in treatments that have turned once-fatal blood cancers into manageable chronic conditions and, in many cases, provided cures. LLS takes a comprehensive approach that also includes patient education, support and advocacy, which has helped drive significant progress for blood cancer patients and their families.
But there's still more work to be done. LLS's strategy focuses on accelerating cures and treatments, improving healthcare delivery and supporting and empowering every patient in every community.
'If everyone had timely and equitable access to the best treatments available right now, patients would gain even more years of life,' said Gwen Nichols, M.D., chief medical officer of LLS. 'This is why LLS works so hard to give patients and families the financial, educational and emotional support they need to advocate for their best care. We are also a leader in health services research, generating evidence that can be used to improve healthcare practice and policy so more people can benefit from the breakthrough treatments we've funded.'
'To achieve our bold goal, we need the support of everyone,' said Kolb. 'Our work isn't possible without the collaboration of the scientific community, healthcare professionals, policymakers and the generosity of our donors, volunteers and supporters. Together, we can push forward innovations that ultimately save and improve lives.'
About The Leukemia & Lymphoma Society (LLS)
The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission: Cure blood cancer and improve the quality of life of all patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949, LLS has regions throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Mon through Fri, 9 a.m. to 9 p.m. ET.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
ZoomCare Opens New Clinic in Happy Valley
The company will host an Open House for the community on Jun. 13 PORTLAND, Ore., June 10, 2025 /PRNewswire/ -- ZoomCare, a network of neighborhood clinics serving a wide variety of healthcare needs, today announced the opening of a new clinic to serve the community of Happy Valley. The new clinic is located at 17155 SE Sunnyside Road, Suite #160 in the Happy Valley Crossroads Shopping Center. The clinic will be open seven days a week. Staffed with board-certified providers who cater to a broad range of illnesses and injuries, the Happy Valley clinic will also include preventive care services. The location features five exam rooms and offers on-site labs and prescriptions, allowing patients to leave with medications in hand. Since 2006, ZoomCare has been known for its patient experience, which is focused on compassion, quality, and efficiency. "ZoomCare believes you shouldn't have to travel far to receive excellent care," said Jeff Fee, Chief Executive Officer of ZoomCare. "We are thrilled to join the Happy Valley community. Opening this new location aligns perfectly with our mission to make healthcare easy and accessible for everyone." The company will celebrate the new clinic opening with an Open House event on Friday, Jun. 13, from 11 a.m. - 2 p.m. The Open House is open to the public and will offer free specialty coffee drinks and Italian sodas, fun giveaways, and a chance to meet the provider team and see the new clinic space. "This Open House is an excellent opportunity for our providers and clinic staff to get to know the people of Happy Valley," said Jennifer Alemany, Director of Clinical Operations in Portland. "We hope folks will come by, meet our team, and learn more about how ZoomCare can help with their healthcare needs now and in the future!" ZoomCare accepts Medicare and Medicare Advantage at all of its 47 locations in Oregon and Washington. Using Medicare-certified software platform Athenahealth, ZoomCare can access and share electronic health records with other providers and health systems. This certified software platform also lets ZoomCare establish partnerships with large health systems and insurance plans to increase patient access to primary, urgent, emergency, and specialty care. About ZoomCareZoomCare's vision is to make healthcare easy. Founded in 2006 in Portland, Oregon, ZoomCare operates more than 47 urgent, primary, emergency care, and specialty locations throughout Oregon and Washington. With conveniently located neighborhood clinics, plus evening and weekend hours, ZoomCare is committed to providing better access to healthcare and delivering evidence-based care with kindness at every visit. For more information, visit Follow ZoomCare on Facebook, Instagram, LinkedIn, and X. Media ContactAmanda Gibbs Director of Communications agibbs@ View original content to download multimedia: SOURCE ZoomCare
Yahoo
an hour ago
- Yahoo
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its Annual Shareholders Meeting will begin at 9:30 a.m. ET. on June 18, 2025, and will be conducted in a virtual format only. Registration for attendees will start at 9:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests. Webcast Information: Date: Wednesday, June 18, 2025 Time: 9:30 a.m. ET A live webcast and replay will be accessible from the Company's website at and at About MiNK Therapeutics MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of allogeneic invariant natural killer T (iNKT) cell therapies and precision-targeted immune technologies. MiNK's proprietary platform is designed to restore immune balance and drive cytotoxic immune responses across cancer, immune-mediated diseases, and pulmonary immune failure. MiNK's lead asset, AGENT-797, is an off-the-shelf, allogeneic iNKT cell therapy currently in clinical development for the treatment of graft-versus-host disease (GvHD), solid tumors, and critical pulmonary immune collapse. MiNK is also advancing a pipeline of T cell receptor (TCR)-based therapies and neoantigen discovery tools that enable tumor- and tissue-specific immune activation with broad potential application. With a scalable, cryopreserved manufacturing process and a differentiated mechanism that bridges innate and adaptive immunity, MiNK is committed to developing next-generation immune reconstitution therapies that are accessible, durable, and applicable across a wide range of indications. For more information, visit or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and social media channels. Investor Contact917-362-1370 investor@ Media Contact781-674-4428communications@ in to access your portfolio
Yahoo
an hour ago
- Yahoo
Nutrishop Co-Founder & 75-Year-Old Father Team Up for 24th Race This Father's Day
Father-daughter duo turns shared finish lines into a living testament that age is no barrier to wellness OLYMPIC VALLEY, Calif., June 10, 2025 /PRNewswire/ -- On Saturday, June 14, Nutrishop Co-Founder Tania McLendon, 51, of Incline Village, Nev., and her 75-year-old father, Anthony Nahale, of Ladera Ranch, Calif., will mark their 24th race together by taking on the Big Blue Adventures Olympic Valley 8-Miler—just one more chapter in a story that began more than a decade ago. The father-daughter duo, who often place in the top five for their age groups, crossed their first finish line in 2013 after McLendon persuaded her dad to join her for the Los Angeles New Year's Race. Since then, their racing journey has taken them from Disneyland, Kauai, and Alaska to Wyoming's Grand Tetons and Rome's Colosseum. In October, the pair will travel to Nahale's ancestral roots in Japan for the Tokyo Legacy Half Marathon. "What started as a way to share my passion for running with my dad has turned into a lifelong adventure filled with unforgettable moments," said McLendon. "Our story proves that age is not a barrier; it's never too late to start healthy habits." Building a Legacy of HealthMcLendon ran cross country in high school and later for Cal State Fullerton on a partial scholarship. Today, she still moves daily—walking or hiking 5–7 miles at Tahoe's altitude and lifting weights three times a week—but the miles shared with her dad have given her training new meaning. "The memories we've made together are priceless," she said. Nahale didn't begin running until his mid-40s. At 50, he started weekly runs on Saturdays with some friends at Dana Point Harbor. Encouraged by his daughter, he added weight training in his mid-50s. Today, he logs about 1,000 miles annually, including a mix of 5Ks, 10Ks, and half marathon races. One of Nahale's proudest and most unforgettable accomplishments so far was finishing his third marathon in Los Angeles just five days before turning 65. Another came when he and McLendon completed their first international half marathon in Rome last October. Nahale's top tips: start small, build gradually, and invest in quality shoes (he replaces his every six months). McLendon's advice: enjoy the journey, give yourself grace, and remember that consistency beats perfection, so find an approach that works for you. Fueling Their Finish LinesMcLendon credits her consistent cross-training and nutrition regimen for staying fit, healthy and injury-free. Her go-to supplements range from high-quality protein to targeted recovery blends available exclusively through On race days, she never competes without Stance Supplements Power ATP, XP2 Crossover, BCAA Complex, and XP2 Salthead Electrolyte Formula. Nahale's diet focuses on lean proteins like fish and chicken, limited sugar, whole grains, and hydration with electrolytes. He supplements daily with Forza Pro Protein, calcium, magnesium, Trailhead Collagen, and BCAA Complex, and fuels race days with energy gels and pH Labs Glumatic for recovery. A Father's Day Call to ActionWith Father's Day approaching, McLendon and Nahale hope their story inspires others to start their own wellness traditions—whether it's running, hiking, biking, cooking nutritious meals, or just spending more intentional time together. "Shared activities build memories," said Nahale. "Find your healthy adventure, whatever it is, and make it a lifelong habit." Need help starting a family fitness tradition? Visit your local Nutrishop for personalized tips and supplement guidance. About NutrishopFounded in 2003, Nutrishop has become a trusted name in health and wellness, helping individuals reach their fitness and nutrition goals. With franchisee-owned stores nationwide, the brand offers exclusive dietary supplements, body composition assessments, one-on-one support, and nutritional guidance—all backed by a low-price guarantee. Committed to exceptional customer service and community support, Nutrishop empowers customers to live healthier, happier lives. For more information, visit and follow @NutrishopUSA on Instagram. Interested in franchise opportunities? Visit to learn more. View original content to download multimedia: SOURCE Nutrishop Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data